Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

Ian D. Hay; I. Ross McDougall; James C. Sisson

doi:10.2967/jnumed.108.052654

Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

Ian D. Hay, I. Ross McDougall, James C. Sisson

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

Original language	English (US)
Pages (from-to)	1395-1397
Number of pages	3
Journal	Journal of Nuclear Medicine
Volume	49
Issue number	8
DOIs	https://doi.org/10.2967/jnumed.108.052654
State	Published - Aug 1 2008

Keywords

Ablation
Endocrinology
Oncology
Radioiodine
Radionuclide therapy
Thyroid carcinoma

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2967/jnumed.108.052654

Cite this

@article{761f10b1cd994b958b37d19cf032dba0,

title = "Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma",

abstract = "We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.",

keywords = "Ablation, Endocrinology, Oncology, Radioiodine, Radionuclide therapy, Thyroid carcinoma",

author = "Hay, {Ian D.} and McDougall, {I. Ross} and Sisson, {James C.}",

year = "2008",

month = aug,

day = "1",

doi = "10.2967/jnumed.108.052654",

language = "English (US)",

volume = "49",

pages = "1395--1397",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "8",

}

TY - JOUR

T1 - Perspective

T2 - The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

AU - Hay, Ian D.

AU - McDougall, I. Ross

AU - Sisson, James C.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

AB - We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

KW - Ablation

KW - Endocrinology

KW - Oncology

KW - Radioiodine

KW - Radionuclide therapy

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=48749128137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749128137&partnerID=8YFLogxK

U2 - 10.2967/jnumed.108.052654

DO - 10.2967/jnumed.108.052654

M3 - Article

AN - SCOPUS:48749128137

SN - 0161-5505

VL - 49

SP - 1395

EP - 1397

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 8

ER -

Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this